Platelet count > ,/mm^ =<  weeks prior to randomization
Platelet count ? ,/mm
Platelet count >= ,/mm^
Within  weeks prior to randomization: Platelet count must be >= ,/mm^
Platelet count >= ,/mm^
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Re-registration: platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^, within  weeks of randomization
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count of >= ,/mm^
Platelet count ?  x ^/L (,/mm)
Platelet count ? ,/mm
Platelet count at least ,/mm.
Platelet count > ,/mm
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^, performed within  days of treatment initiation
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count > ,/mm^
Platelet count >= , per mm^
Platelet count <,/mm
Platelet count ? ,/mm^
platelet count must be ? ,/mm; and
Platelet count ? ,/mm^
Platelet count >= ,/mm^
Platelet count >= , mm^ within  days of enrollment to trial
Platelet count >= ,/mm^
Platelet count is >= ,/mm^ (<=  days prior to enrollment)
Platelet count of >= ,/mm^ before starting therapy
Evident myeloid and platelet engraftment: Absolute neutrophil count (ANC) > /mm^ and platelet count > ,/ mm^
Platelet count >= ,/mm^
Platelet count >= , platelet/mm^ (  ^/L)
Platelet count >= ,/mm^
Platelet count >= , /mm^
Platelet count >=  x ^/L (>= , per mm^)
Platelet count >= ,/mm^ (performed within  days of treatment initiation)
Platelet count > ,/mm^
Platelet count >  /mm^
Platelet count >= ,/mm^
Platelet count greater than ,/mm^
Platelet count >,/mm
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
PART I: Platelet count >= ,/mm^
PART II: Platelet count >= ,/mm^
Platelet count greater than ,/mm^
Platelet count greater than ,/mm^
Platelet count >= ,/mm^
Should be performed within  days of treatment initiation: platelet count ?  x ^/L (?, per mm^)
Platelet count >= ,/mm^
Platelet count ?,/mm
Platelet count >= ,/mm^
Platelet count ? ,/mm^
Platelet count of > ,/mm^L
Platelet count >= ,/mm^
Platelet count less than /mm^
Platelet count greater than ,/mm^
Platelet count >= ,/mm^
COHORT : ENDOMETRIAL CANCER: Platelet count >= ,/mm^ (>=  X ^/L)
Platelet count >= ,/mm^ within  days prior to randomization
Platelet count >=  x ^/L (> , per mm^)
Platelet count >= ,/mm^
Platelet count < ,/mm^
Platelet count > ,/mm^
Platelet count >=  /mm (within  days before starting therapy)
Platelet count >=  /mm^ (within  days before starting therapy)
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >=  x ^/L (> , per mm^)
Platelet count >=  x ^/L (> , per mm^)
Platelet count >= ,/mm^
Platelet count at least ,/mm^ or at least  x ^/L
Platelet count >=  x ^/L (>= , per mm^)
Platelet count >= ,/mm^
Platelet count >=  x ^/L (>, per mm^).
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count ?, /mm;
Platelet count >= ,/mm^
Platelet count of > ,/mm^
Platelet count >=  x ^/L (> , per mm^)
Compromised hematopoietic function (hemoglobin <. g/dL; lymphocyte count < mm; neutrophil count < mm; platelet count <, mm).
Platelet count >=  x ^/L (>= , per mm^)
Platelet count < ,/mm^ at the time of screening
Platelet count >= ,/mm^
Platelet count >=  x ^/L (> , per mm^)
Platelet count >=  x ^/L (>= , per mm^)
Platelet count greater than ,/mm^
Platelet count >=  x ^/L (>= , per mm^)
Platelet count >=  x ^/L (>= , per mm^)
Platelet count <,/mm
Platelet >,/ mm
Determined within  weeks of treatment initiation: Platelet count >= ,/mm^ ( x ^/L)
Platelet count ? ,/ mm^
Platelet count >= ,/mm^ (within  days of enrollment)
Platelet count < ,/mm^
Platelet count >= ,/mm^
Platelet count > ,/mm^
Platelet count >=  x ^/L (> , per mm^).
Platelet count >=,/mm^ [ x ^/L]
Platelet count >=  x ^/L (>= , per mm^)
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >=  x ^/L (>= , per mm^)
Platelet count >= ,/mm^ (>=  X ^/L)
Platelet count of >= ,/mm^
Platelet count >= ,/mm^
Platelet count >=  x ^/L (>= , per mm^)
Platelet count >= ,/mm^
Platelet count >=  x ^/L (>, per mm^)
Platelet count >= ,/mm^
Platelet count < ,/mm^
Completed within  days of surgery: Platelet count ? ,/mm
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >=  x ^/L (,/mm^)
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >=  x ^/L (> , per mm^)
Platelet count >= ,/mm^
Platelet count < ,/mm^
Platelet count >=  x ^/L (>= , per mm^)
Platelet count >= /mm^
PRIOR TO LYMPHODEPLETION: Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= , /mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count ?  x ^/L (? , per mm^)
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count < , per mm^
Platelet count ? ,/mm;
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count ? ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count ? ,/mm.
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count =< , per mm^
Within  days of first vaccination: Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count < ,/mm
Platelet count >= ,/mm^
Platelet count >= , platelet/mm^ (  ^/L)
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^ (  ^/L)
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count of > ,/mm^
Platelet count >= , per mm^ AND
Platelet count ? ,/mm
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count of >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= , /mm^
Platelet count of >= ,/mm^
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^ within  days prior to starting treatment
Platelet > , platelet/mm^
Platelet count ?,/mm.
Platelet count >= ,/mm^ (repeat if more than  days before the first dose)
Platelet count ? ,/mm ( x /L)
Platelet count >,/mm
Platelet count >= ,/mm^
Platelet count ?,/mm
Platelet count ? ,/mm^
Within  days prior to randomization: Platelet count must be >= ,/mm^
Platelet count >= ,/mm^
Platelet count greater than ,/mm
Platelet count >= ,/mm^.
Platelet count >= ,/mm
Platelet count >=  x ^/L (>=, per mm^).
Platelet count >=  x ^/L (> , per mm^), except for patients with HCC for whom a platelet count > , per mm^ is allowed
Platelet count >= ,/mm^
Platelet count >=  x ^/L (> , per mm^)
Platelet count >= , per mm^
Platelet count >= , /mm^
Platelet count >= , /mm^
Platelet count >= , /mm^
Platelet count >= ,/mm^
Platelet count > ,/mm
Platelet count >= ,/mm^
Platelet count >= ,/mm^ [ x ^/L],
Platelet count >= ,/mm^
Platelet count must be >= ,/mm^ within  days before randomization
Performed within  days prior to study: Platelet count >= ,/mm^
Platelet count < ,/mm^, or
Platelet count > ,/mm^
Platelet count >=  x ^/L (>= , per mm^)
Platelet >= ,/ mm^
Platelet count >= ,/mm^
Platelet count > ,/mm^
Platelet count >= , per mm^
Platelet count greater than ,/mm^
Platelet count >= /mm^
Platelet count >= , /mm^
Platelet count >= ,/mm^ or >=  x ^/L
Platelet count >= ,/mm^
Platelet count must be >= ,/mm^
Platelet count < , / mm^
Platelet count >= ,/mm^
Platelet count greater than ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^ within four weeks prior to randomization
Platelet count >= ,/mm
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count ? ,/mm^
Platelet count at least ,/mm
Platelet count >=  K/mm^
Platelet count ? ,/mm
Platelet count >= ,/mm^
Platelet count of >,/mm
Platelet count >= ,/mm^
Platelet count ? . x  /mm
Platelet count > ,/mm^
Platelet count less than ,/mm^
Platelet count > ,/mm^
Platelet >= ,/ mm^
Platelet count ?  x ^/L (,/mm)
Platelet count >=  /mm^ (within  days before starting therapy)
Platelet count > ,/mm^
Platelet count: ? ,/mm
Platelet count =< ,/mm^
Platelet count > ,/mm^
Platelet count ? ,/mm (? ,/mm if myeloma involvement in the bone marrow is > %. Subjects should not have received platelet transfusions for at least  week prior to obtaining the screening platelet count.)
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
PHASE I: Platelet count >= , mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
platelet count > ,/mm
Platelet count of < ,/mm^
Platelet count < ,/mm^
Platelet count ? ,/mm
Platelet count >= ,/mm^
Platelet count < ,/mm^
Within  days prior to initiation of protocol treatment: Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count must be > ,/mm^
Platelet count >= ,/mm^
Platelet count of >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm
Platelet > ,/mm^
Platelet count >= /mm^ (within  days before starting therapy)
Platelet count of more than ,/mm^
Platelet count >= , cell/mm^
Platelet count >= ,/mm^
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count ? , /mm
Platelet count >= , /mm^
Platelet count at least ,/mm
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count > = , /mm
Platelet count >= ,/mm^
Platelet count of >= ,/mm^
Platelet Count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count greater than ,/mm^
Platelet count of >= ,/mm^
Platelet count >= ,/mm^
Platelet count at least ,/mm^ or at least  x ^/L
Platelet count > /mm^
Platelet count >= ,/mm^
Platelet count of  >= ,/mm^
Platelet count >=  x ^/L (>= , per mm^)
Platelet count >=  x ^/L (>= , per mm^)
Platelet count ? x /L (?,/mm)
Platelet count >=  x ^/L (> , per mm^)
Platelet count >= ,/mm^
Platelet >= ,/mm^
Platelet count ? ,/mm
Platelet >= ,/mm^
Platelet count >= ,/mm^ (part  & )
Platelet count >= ,/mm^
Platelet count >= , /mm^
Platelet count >= ,/mm^
Platelet count ? . x  /mm
Platelet count ?, //mm (?  /L).
Platelet count ? . x ^/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count > , /mm^
Platelet count >= ,/mm^
Platelet count >= /mm^
Platelet count > ,/mm^
Platelet >= ,/mm^
Platelet count >= /mm^
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
DONOR: platelet count , to ,/mm^
Platelet count >= ,/mm^
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet Count > ,/mm
A platelet count of more than ,/mm^
TREATMENT: Platelet count greater than ,/mm^
Platelet count greater than ,/mm^
Platelet count >= , platelets/mm^
Platelet count >= ,/mm^
Platelet count >= , platelets/mm^
Platelet count must be >= ,/mm^
Platelet count >=  x ^/mm^
Platelet count ?,/mm
Platelet count < ,/mm^
Platelet count >= ,/mm^
Platelet count of >= , mm^
Platelet count ? ,/mm
Platelet count >=  K/mm^ un-transfused
Platelet count > , mm^
Platelet count >= /mm^
Platelet count >= ,/mm^
Platelet count < , / mm^
Platelet count > ,/mm^
Platelet count < ,/mm.
Platelet count >= /mm^
Platelet count >= ,/mm^ within  days of starting therapy
Platelet count > ,/mm^
Platelet count >=,/mm^
Platelet count ? ,/mm
Platelet count    /L (,/mm)
Does the subject have a platelet count ? ,/mm?
Platelet count < , per mm
Platelet count > ,/mm^
Platelet count > ,/mm^
Platelet count > ,/mm^
Platelet count < , per mm
Platelet count ? ,/mm.
Platelet count >= ,/mm^
Platelet count >= /mm^
Platelet count >= /mm^
Cohort A: Platelet count greater than ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^ ( x ^/L)
Platelet count >= ,/mm^
Platelet count greater than ,/mm^
Platelet Count ? ,/mm
Platelet count ? ,/mm (? ,/mm if myeloma involvement in the bone marrow is > %) within  days prior to randomization. Patients should not have received platelet transfusions for at least  week prior to obtaining the screening platelet count.
Platelet count >,/mm.
Platelet count =< ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
platelet count > ,/mm^
Platelet >= ,/mm
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= , mm^-
Platelet count >=  x ^/L (>= , per mm^)
Platelet count >= ,/mm^
Platelet count greater than ,/mm^
Platelet count >= ,/mm^
Platelet count ? .  /mm
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= , mm^-
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count > ,/mm^ and < ,/mm^ within  days prior to study entry
Platelet count > ,/mm^
Platelet count > ,/mm^
Platelet count ? ,/mm
Platelet count >  /mm^
Platelet count ? ,/mm
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count of =< ,/mm^
Platelet count >= ,/mm^
Platelet count >,/mm within  weeks screening
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^ within  days of enrollment
Platelet count > ,/mm^
Platelet count > ,/mm^
Platelet count greater than ,/mm^
Platelet count >=  x ^/L (>= , per mm^)
Platelet count >= ,/mm^
Platelet count ? ,/mm^
- Platelet count of > ,/mm
Platelet count >= ,/mm^
Platelet count >,/ mm
Platelet count > ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet count >= ,/mm^
Platelet ? /mm
Platelet count >= ,/mm^
Platelet count > ,/mm^
- Platelet count of > ,/mm
Platelet count < ,/mm^
Platelet count >= ,/mm^
Platelet count > ,/mm
Platelet count >=,/mm^.